Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symp...
Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms
About this item
Full title
Author / Creator
Pavlovic, Nikola , Chierchia, Gian-Battista , Velagic, Vedran , Hermida, Jean Sylvain , Healey, Stewart , Arena, Giuseppe , Badenco, Nicolas , Meyer, Christian , Chen, Jian , Iacopino, Saverio , Anselme, Frédéric , Dekker, Lukas , Scazzuso, Fernando , Packer, Douglas L , de Asmundis, Carlo , Pitschner, Heinz-Friedrich , Piazza, Fabio Di , Kaplon, Rachelle E , Kuniss, Malte and Cryo-FIRST Investigators
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Cryoballoon ablation (CBA) as a first-line rhythm control strategy is superior to antiarrhythmic drugs (AADs) for preventing atrial fibrillation (AF) recurrence; the impact of first-line CBA on quality of life (QoL) and symptoms has not been well characterized.
Patients aged 18 to 75 with symptomatic paroxysmal AF naïve to rhythm control therapy...
Alternative Titles
Full title
Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms
Authors, Artists and Contributors
Author / Creator
Chierchia, Gian-Battista
Velagic, Vedran
Hermida, Jean Sylvain
Healey, Stewart
Arena, Giuseppe
Badenco, Nicolas
Meyer, Christian
Chen, Jian
Iacopino, Saverio
Anselme, Frédéric
Dekker, Lukas
Scazzuso, Fernando
Packer, Douglas L
de Asmundis, Carlo
Pitschner, Heinz-Friedrich
Piazza, Fabio Di
Kaplon, Rachelle E
Kuniss, Malte
Cryo-FIRST Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03572217v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03572217v1
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2021.08.007
